USANA Health Sciences (USNA) 28th Annual ICR Conference 2026 summary
Event summary combining transcript, slides, and related documents.
28th Annual ICR Conference 2026 summary
13 Apr, 2026Business overview and strategic direction
Focus on premium vitamins, supplements, and health products, with recent expansion through M&A to broaden customer base and channels.
Omnichannel growth is a key strategy, with new brands and acquisitions supplementing the core direct selling business.
Non-direct selling revenue is projected to rise from negligible in 2024 to about 16% in 2025 and low 20s% in 2026.
Capital allocation prioritizes investment in brands, inventory, and working capital for growth, with share repurchases as a secondary use of excess capital.
Infrastructure, supply chain, and international expansion capabilities are leveraged to support acquired brands.
Growth drivers and brand performance
Rise Wellness, acquired as a small DTC protein bar company, grew from $5M in 2024 to over $16M in 2025, with 2026 projections of $65–$80M.
Protein Pop, a new product under Rise, launched in March and quickly secured national retail placements at Target and Costco.
Hiya, acquired in December 2023, is forecasted to reach $132M in 2025 and $140–$155M in 2026, with international expansion into Canada and the UK in Q1 2026.
Retail channel expansion and tailored product development for large accounts are driving rapid growth.
Customer base for new products is broad, with Protein Pop targeting women and those seeking convenient, clean protein options.
Core direct selling business and leadership changes
CEO transition announced, with Kevin Guest returning to reinvigorate the business and leverage strong sales force connections.
Brand messaging and awareness are key focus areas to broaden the customer funnel and drive satisfaction.
Cost alignment and right-sizing initiatives are underway, with details to be provided in the Q4 update.
Direct selling segment is expected to decline mid-single digits in 2026, but leadership is optimistic about a path to future growth.
Latest events from USANA Health Sciences
- 2026 outlook targets up to 8% sales growth, driven by retail and tech investments.USNA
Q4 202510 Apr 2026 - Virtual annual meeting to vote on directors, auditor, and executive pay, with focus on governance and ESG.USNA
Proxy filing7 Apr 2026 - Hiya acquisition and agile innovation drive growth, with China and global markets as key priorities.USNA
Sidoti Small-Cap Virtual Conference3 Feb 2026 - Q2 sales and EPS declined sharply, but strong liquidity supports ongoing strategic initiatives.USNA
Q2 20243 Feb 2026 - Active associate growth and accelerated product innovation drive global expansion and future growth.USNA
Small-Cap Growth Virtual Investor Conference1 Feb 2026 - China drives short-term gains as focus shifts to associates, innovation, and disciplined growth.USNA
Water Tower Research Consumer Products Virtual Investor Conference 20241 Feb 2026 - Q3 2024 net sales declined 6.2% year-over-year, with EPS at $0.56 and cash at $365M.USNA
Q3 202419 Jan 2026 - $205M acquisition of a children's wellness brand accelerates growth and market leadership.USNA
M&A Announcement10 Jan 2026 - Acquisition of Hiya Health accelerates growth in children's supplements and expands market reach.USNA
27th Annual ICR Conference 202510 Jan 2026